Rayna J S Anijs
Overview
Explore the profile of Rayna J S Anijs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buijs J, van Beijnum R, Anijs R, Laghmani E, Sensuk L, Minderhoud C, et al.
J Thromb Thrombolysis
. 2023 Dec;
57(3):370-380.
PMID: 38066386
Novel biomarkers are needed to improve current imperfect risk prediction models for cancer-associated thrombosis (CAT). We recently identified an RNA-sequencing profile that associates with CAT in colorectal cancer (CRC) patients,...
2.
Anijs R, Cannegieter S, Versteeg H, Buijs J
J Thromb Haemost
. 2023 Aug;
21(9):2638-2639.
PMID: 37597903
No abstract available.
3.
Crobach M, Anijs R, Braekkan S, Severinsen M, Hammerstrom J, Skille H, et al.
Blood Adv
. 2023 Apr;
7(15):4072-4079.
PMID: 37013958
Patients with cancer have an increased risk of developing venous thromboembolism (VTE), and this combination is reported to result in poorer survival compared with cancer alone. This study aimed to...
4.
Anijs R, Nguyen Y, Cannegieter S, Versteeg H, Buijs J
J Thromb Haemost
. 2023 Jan;
21(1):7-17.
PMID: 36695398
MicroRNAs (miRNAs) are small noncoding RNAs with gene regulatory functions and are commonly dysregulated in disease states. As miRNAs are relatively stable, easily measured, and accessible from plasma or other...
5.
Anijs R, Laghmani E, Unlu B, Kielbasa S, Mei H, Cannegieter S, et al.
Res Pract Thromb Haemost
. 2022 Jul;
6(5):e12749.
PMID: 35794963
Background: Colorectal cancer patients have an increased risk of developing venous thromboembolism (VTE), resulting in increased morbidity and mortality. Because the exact mechanism is yet unknown, risk prediction is still...